Reagents
Ended Purchase Order Awarded
- Contract number
- 75N90023P00462
- Awardee
-
Omixon, Inc. UEI DW2PPM9LS8W4
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $20,445
Award facts
- Contract value 100% obligated
- $20,445.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Cambridge, MA 02142, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract 75N90023P00462?
75N90023P00462 was awarded to Omixon, Inc. by NIH Clinical Center (National Institutes of Health) on May 31, 2023.
How much is contract 75N90023P00462 worth?
The government has obligated $20,445 on 75N90023P00462.
Was contract 75N90023P00462 competed?
The extent of competition for 75N90023P00462 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award